The global market for Polycarbonate for Medical Use was estimated to be worth US$ 1749 million in 2024 and is forecast to a readjusted size of US$ 3106 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Polycarbonate for Medical Use cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Polycarbonate (PC) is one of the engineering thermoplastic materials most commonly used and most widely tested in the medical device industry today. Its inherent strength, excellent optical clarity, high heat distortion temperature, and dimensional stability make it an ideal material choice for demanding, critical healthcare applications. This report focuses on Polycarbonate used for medical use.
Key Trends
1. Technological development
Products produced by non-phosgene method have obvious price advantages. In the release of production capacity in the next few years, the non-phosgene method occupies most of the market share
2. Medical demand will remain strong
Affected by the epidemic, the demand for PC resin in the medical field has been growing strongly. At present, the global control of the epidemic has not shown any significant benefits. Therefore, the strong demand in the medical field will continue for some time in the future.
3. Environmentally friendly raw materials
There are several large companies on the market that use biodegradable raw materials to produce PC products. The current amount is not very large, and the big future may be a development direction.
This report aims to provide a comprehensive presentation of the global market for Polycarbonate for Medical Use, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polycarbonate for Medical Use by region & country, by Type, and by Application.
The Polycarbonate for Medical Use market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polycarbonate for Medical Use.
Market Segmentation
By Company
- Teijin Limited
- Sinopec
- Covestro
- SABIC
- Mitsubishi
- Trinseo
- Lotte Chemical
- Luxi Chemical
- Wanhua Chemical
Segment by Type
- Phosgene type
- Non-Phosgene type
Segment by Application
- Face Protection Products
- Injection and Drug Delivery System
- Blood Filtration and Oxygenator
- Others
By Region
- North America
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Polycarbonate for Medical Use manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Polycarbonate for Medical Use in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Polycarbonate for Medical Use in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Polycarbonate for Medical Use Product Introduction
- 1.2 Global Polycarbonate for Medical Use Market Size Forecast
- 1.2.1 Global Polycarbonate for Medical Use Sales Value (2020-2031)
- 1.2.2 Global Polycarbonate for Medical Use Sales Volume (2020-2031)
- 1.2.3 Global Polycarbonate for Medical Use Sales Price (2020-2031)
- 1.3 Polycarbonate for Medical Use Market Trends & Drivers
- 1.3.1 Polycarbonate for Medical Use Industry Trends
- 1.3.2 Polycarbonate for Medical Use Market Drivers & Opportunity
- 1.3.3 Polycarbonate for Medical Use Market Challenges
- 1.3.4 Polycarbonate for Medical Use Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Polycarbonate for Medical Use Players Revenue Ranking (2024)
- 2.2 Global Polycarbonate for Medical Use Revenue by Company (2020-2025)
- 2.3 Global Polycarbonate for Medical Use Players Sales Volume Ranking (2024)
- 2.4 Global Polycarbonate for Medical Use Sales Volume by Company Players (2020-2025)
- 2.5 Global Polycarbonate for Medical Use Average Price by Company (2020-2025)
- 2.6 Key Manufacturers Polycarbonate for Medical Use Manufacturing Base and Headquarters
- 2.7 Key Manufacturers Polycarbonate for Medical Use Product Offered
- 2.8 Key Manufacturers Time to Begin Mass Production of Polycarbonate for Medical Use
- 2.9 Polycarbonate for Medical Use Market Competitive Analysis
- 2.9.1 Polycarbonate for Medical Use Market Concentration Rate (2020-2025)
- 2.9.2 Global 5 and 10 Largest Manufacturers by Polycarbonate for Medical Use Revenue in 2024
- 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycarbonate for Medical Use as of 2024)
- 2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 Phosgene type
- 3.1.2 Non-Phosgene type
- 3.2 Global Polycarbonate for Medical Use Sales Value by Type
- 3.2.1 Global Polycarbonate for Medical Use Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Polycarbonate for Medical Use Sales Value, by Type (2020-2031)
- 3.2.3 Global Polycarbonate for Medical Use Sales Value, by Type (%) (2020-2031)
- 3.3 Global Polycarbonate for Medical Use Sales Volume by Type
- 3.3.1 Global Polycarbonate for Medical Use Sales Volume by Type (2020 VS 2024 VS 2031)
- 3.3.2 Global Polycarbonate for Medical Use Sales Volume, by Type (2020-2031)
- 3.3.3 Global Polycarbonate for Medical Use Sales Volume, by Type (%) (2020-2031)
- 3.4 Global Polycarbonate for Medical Use Average Price by Type (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Face Protection Products
- 4.1.2 Injection and Drug Delivery System
- 4.1.3 Blood Filtration and Oxygenator
- 4.1.4 Others
- 4.2 Global Polycarbonate for Medical Use Sales Value by Application
- 4.2.1 Global Polycarbonate for Medical Use Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Polycarbonate for Medical Use Sales Value, by Application (2020-2031)
- 4.2.3 Global Polycarbonate for Medical Use Sales Value, by Application (%) (2020-2031)
- 4.3 Global Polycarbonate for Medical Use Sales Volume by Application
- 4.3.1 Global Polycarbonate for Medical Use Sales Volume by Application (2020 VS 2024 VS 2031)
- 4.3.2 Global Polycarbonate for Medical Use Sales Volume, by Application (2020-2031)
- 4.3.3 Global Polycarbonate for Medical Use Sales Volume, by Application (%) (2020-2031)
- 4.4 Global Polycarbonate for Medical Use Average Price by Application (2020-2031)
5 Segmentation by Region
- 5.1 Global Polycarbonate for Medical Use Sales Value by Region
- 5.1.1 Global Polycarbonate for Medical Use Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Polycarbonate for Medical Use Sales Value by Region (2020-2025)
- 5.1.3 Global Polycarbonate for Medical Use Sales Value by Region (2026-2031)
- 5.1.4 Global Polycarbonate for Medical Use Sales Value by Region (%), (2020-2031)
- 5.2 Global Polycarbonate for Medical Use Sales Volume by Region
- 5.2.1 Global Polycarbonate for Medical Use Sales Volume by Region: 2020 VS 2024 VS 2031
- 5.2.2 Global Polycarbonate for Medical Use Sales Volume by Region (2020-2025)
- 5.2.3 Global Polycarbonate for Medical Use Sales Volume by Region (2026-2031)
- 5.2.4 Global Polycarbonate for Medical Use Sales Volume by Region (%), (2020-2031)
- 5.3 Global Polycarbonate for Medical Use Average Price by Region (2020-2031)
- 5.4 North America
- 5.4.1 North America Polycarbonate for Medical Use Sales Value, 2020-2031
- 5.4.2 North America Polycarbonate for Medical Use Sales Value by Country (%), 2024 VS 2031
- 5.5 Europe
- 5.5.1 Europe Polycarbonate for Medical Use Sales Value, 2020-2031
- 5.5.2 Europe Polycarbonate for Medical Use Sales Value by Country (%), 2024 VS 2031
- 5.6 Asia Pacific
- 5.6.1 Asia Pacific Polycarbonate for Medical Use Sales Value, 2020-2031
- 5.6.2 Asia Pacific Polycarbonate for Medical Use Sales Value by Region (%), 2024 VS 2031
- 5.7 South America
- 5.7.1 South America Polycarbonate for Medical Use Sales Value, 2020-2031
- 5.7.2 South America Polycarbonate for Medical Use Sales Value by Country (%), 2024 VS 2031
- 5.8 Middle East & Africa
- 5.8.1 Middle East & Africa Polycarbonate for Medical Use Sales Value, 2020-2031
- 5.8.2 Middle East & Africa Polycarbonate for Medical Use Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Polycarbonate for Medical Use Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Polycarbonate for Medical Use Sales Value and Sales Volume
- 6.2.1 Key Countries/Regions Polycarbonate for Medical Use Sales Value, 2020-2031
- 6.2.2 Key Countries/Regions Polycarbonate for Medical Use Sales Volume, 2020-2031
- 6.3 United States
- 6.3.1 United States Polycarbonate for Medical Use Sales Value, 2020-2031
- 6.3.2 United States Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Polycarbonate for Medical Use Sales Value, 2020-2031
- 6.4.2 Europe Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Polycarbonate for Medical Use Sales Value, 2020-2031
- 6.5.2 China Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Polycarbonate for Medical Use Sales Value, 2020-2031
- 6.6.2 Japan Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Polycarbonate for Medical Use Sales Value, 2020-2031
- 6.7.2 South Korea Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Polycarbonate for Medical Use Sales Value, 2020-2031
- 6.8.2 Southeast Asia Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Polycarbonate for Medical Use Sales Value, 2020-2031
- 6.9.2 India Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Teijin Limited
- 7.1.1 Teijin Limited Company Information
- 7.1.2 Teijin Limited Introduction and Business Overview
- 7.1.3 Teijin Limited Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 Teijin Limited Polycarbonate for Medical Use Product Offerings
- 7.1.5 Teijin Limited Recent Development
- 7.2 Sinopec
- 7.2.1 Sinopec Company Information
- 7.2.2 Sinopec Introduction and Business Overview
- 7.2.3 Sinopec Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Sinopec Polycarbonate for Medical Use Product Offerings
- 7.2.5 Sinopec Recent Development
- 7.3 Covestro
- 7.3.1 Covestro Company Information
- 7.3.2 Covestro Introduction and Business Overview
- 7.3.3 Covestro Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Covestro Polycarbonate for Medical Use Product Offerings
- 7.3.5 Covestro Recent Development
- 7.4 SABIC
- 7.4.1 SABIC Company Information
- 7.4.2 SABIC Introduction and Business Overview
- 7.4.3 SABIC Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 SABIC Polycarbonate for Medical Use Product Offerings
- 7.4.5 SABIC Recent Development
- 7.5 Mitsubishi
- 7.5.1 Mitsubishi Company Information
- 7.5.2 Mitsubishi Introduction and Business Overview
- 7.5.3 Mitsubishi Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Mitsubishi Polycarbonate for Medical Use Product Offerings
- 7.5.5 Mitsubishi Recent Development
- 7.6 Trinseo
- 7.6.1 Trinseo Company Information
- 7.6.2 Trinseo Introduction and Business Overview
- 7.6.3 Trinseo Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Trinseo Polycarbonate for Medical Use Product Offerings
- 7.6.5 Trinseo Recent Development
- 7.7 Lotte Chemical
- 7.7.1 Lotte Chemical Company Information
- 7.7.2 Lotte Chemical Introduction and Business Overview
- 7.7.3 Lotte Chemical Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 Lotte Chemical Polycarbonate for Medical Use Product Offerings
- 7.7.5 Lotte Chemical Recent Development
- 7.8 Luxi Chemical
- 7.8.1 Luxi Chemical Company Information
- 7.8.2 Luxi Chemical Introduction and Business Overview
- 7.8.3 Luxi Chemical Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 Luxi Chemical Polycarbonate for Medical Use Product Offerings
- 7.8.5 Luxi Chemical Recent Development
- 7.9 Wanhua Chemical
- 7.9.1 Wanhua Chemical Company Information
- 7.9.2 Wanhua Chemical Introduction and Business Overview
- 7.9.3 Wanhua Chemical Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 Wanhua Chemical Polycarbonate for Medical Use Product Offerings
- 7.9.5 Wanhua Chemical Recent Development
8 Industry Chain Analysis
- 8.1 Polycarbonate for Medical Use Industrial Chain
- 8.2 Polycarbonate for Medical Use Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Polycarbonate for Medical Use Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Polycarbonate for Medical Use Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.2 Author Details
- 10.3 Disclaimer